PTCy + Sirolimus/VIC-1911 as GVHD Prophylaxis in Myeloablative PBSC Transplantation

Clinical trial NCT05120570 · COMPLETED

Trial details

NCT number: NCT05120570
Sponsor: Masonic Cancer Center, University of Minnesota
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Leukemia Myelodysplastic Syndromes Myeloproliferative Neoplasm Lymphoma

Start date: 2022-03-17
Primary completion: 2024-09-19
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.